These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4029807)

  • 1. [Experimental nephrotic hyperlipidemia induced in rats by daunorubicin and effects of KCD-232[4-(4'-chlorobenzyloxy)benzyl nicotinate] on lipid metabolism].
    Okada K; Mochizuki T; Itaroku K; Takagi K; Irikura T
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):347-56. PubMed ID: 4029807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice].
    Okada K; Mochizuki T; Shinohara Y; Takahashi S; Takagi K; Irikura T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):331-43. PubMed ID: 6745812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on triglyceride and fatty acid metabolism in rats.
    Yagasaki K; Okada K; Mochizuki T; Takagi K; Irikura T
    Biochem Pharmacol; 1984 Oct; 33(20):3151-63. PubMed ID: 6548383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.
    Okada K; Yagasaki K; Mochizuki T; Takagi K; Irikura T
    Biochem Pharmacol; 1985 Sep; 34(18):3361-7. PubMed ID: 4038342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simultaneous dietary fish oil ingestion and sulfur amino acid supplementation on the lipid metabolism in hepatoma-bearing rats with hyperlipidemia.
    Kawasaki M; Miura Y; Funabiki R; Yagasaki K
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(4):247-54. PubMed ID: 20924147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the changes in lipid metabolism between hepatoma-bearing and lipopolysaccharide-treated rats.
    Kawasaki M; Yagasaki K; Miura Y; Funabiki R
    Biosci Biotechnol Biochem; 2004 Jan; 68(1):72-8. PubMed ID: 14745166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid metabolism in the aorta of daunomycin-induced nephrotic rats.
    Morisaki N; Matsuoka N; Shinomiya M; Mizobuchi M; Saito Y; Kumagai A
    Tohoku J Exp Med; 1983 Oct; 141(2):183-90. PubMed ID: 6648960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng.
    Kwak YS; Kyung JS; Kim JS; Cho JY; Rhee MH
    Biol Pharm Bull; 2010; 33(3):468-72. PubMed ID: 20190411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.
    Kawasaki M; Funabiki R; Yagasaki K
    Lipids; 1998 Sep; 33(9):905-11. PubMed ID: 9778138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
    Zhou X; Ren F; Wei H; Liu L; Shen T; Xu S; Wei J; Ren J; Ni H
    Lipids Health Dis; 2017 Dec; 16(1):239. PubMed ID: 29228954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice.
    Zhang Y; Zhao J; Zhou SF; Yu ZL; Wang XY; Zhu PL; Chu ZS; Pan SY; Xie M; Ko KM
    Lipids Health Dis; 2017 Jan; 16(1):8. PubMed ID: 28086886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid metabolism in daunomycin-induced nephrotic rats (5)].
    Gomikawa S; Inagaki O; Mori H; Fujita Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):985-93. PubMed ID: 2263029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
    Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
    Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
    Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
    Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of KCD-232, a new hypolipidemic agent, on serum lipoprotein changes in hepatoma-bearing rats.
    Irikura T; Takagi K; Okada K; Yagasaki K
    Lipids; 1985 Jul; 20(7):420-4. PubMed ID: 4033362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of hyperlipidemia in hepatoma-bearing rats by dietary fish oil.
    Kawasaki M; Yagasaki K; Miura Y; Funabiki R
    Lipids; 1995 May; 30(5):431-6. PubMed ID: 7637563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters.
    Guo F; Huang C; Liao X; Wang Y; He Y; Feng R; Li Y; Sun C
    Mol Nutr Food Res; 2011 Dec; 55(12):1809-18. PubMed ID: 22038976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T; Mamo JC; Nagano S; Sugisaki T
    Nephron; 1991; 58(1):95-100. PubMed ID: 1857487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.